TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32114466

Group type: EXPERIMENTAL
Intervention: iCBT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: iACT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 60
Study: 35399060

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (LDA)
Number of subjects: 1446

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1446
Study: 34673939

Group type: EXPERIMENTAL
Intervention: 10 min of continuous priming taVNS before lexical training and testing each day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 500 msec of peristimulus taVNS preceding each to-be-learned item
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive sham stimulation
Number of subjects: 0
Study: 32282024

Group type: EXPERIMENTAL
Intervention: Lung cancer screening program websites
Number of subjects: 162

Group type: COMPARATOR
Intervention: Community medical centers
Number of subjects: 162
Study: 35296973

Group type: EXPERIMENTAL
Intervention: Exercise Group 1 (EG-1)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Exercise Group 2 (EG-2)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 105
Study: 32507145

Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) applied to the gastrocnemius muscle.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Stretching of the gastrocnemius muscle (60 seconds, repeated 4 times).
Number of subjects: 80
Study: 36040612

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 37

Group type: COMPARATOR
Intervention: Mannitol (placebo)
Number of subjects: 37
Study: 34610730

Group type: EXPERIMENTAL
Intervention: Plyometric training (12 weeks, jumps on nonconsecutive days)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (non-trained group)
Number of subjects: 41
Study: 32240562

Group type: EXPERIMENTAL
Intervention: Tag-7 gene-modified tumor cells-based vaccine (GMV), injected subcutaneously every 3 weeks until progression or for 2 years.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tag-7 gene-modified tumor cells-based vaccine (GMV) in favorable prognosis (FP) group (MICA level ≤582 pg/mL, n = 15).
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tag-7 gene-modified tumor cells-based vaccine (GMV) in unfavorable prognosis (UF) group (MICA level >582 pg/mL, n = 12).
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tag-7 gene-modified tumor cells-based vaccine (GMV) in patients with stage III-IV MM with FP.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tag-7 gene-modified tumor cells-based vaccine (GMV).
Number of subjects: 80
Study: 616871147

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy (quinapril, losartan, amlodipine, hydrochlorothiazide, bisoprolol) for 6 months
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (31 normotensives of the same age range)
Number of subjects: 95
Study: 36197845

Group type: EXPERIMENTAL
Intervention: Ad26.Filo and MVA-BN-Filo vaccine regimens
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ad26.Filo booster
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 34639299

Group type: EXPERIMENTAL
Intervention: Vegan diet (n = 23)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Meat-rich diet (n = 22)
Number of subjects: 45
Study: 32560911

Group type: EXPERIMENTAL
Intervention: Mental rotation training
Number of subjects: 94

Group type: COMPARATOR
Intervention: No training
Number of subjects: 94
Study: 33252629

Group type: EXPERIMENTAL
Intervention: First-degree family history of breast cancer in AA women
Number of subjects: 3244

Group type: COMPARATOR
Intervention: First-degree family history of breast cancer in White women
Number of subjects: 3244

Group type: EXPERIMENTAL
Intervention: All risk factors collectively in AA women
Number of subjects: 3244
Study: 32459755

Group type: COMPARATOR
Intervention: Primary closure
Number of subjects: 150

Group type: COMPARATOR
Intervention: Secondary closure
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Limberg flap
Number of subjects: 150
Study: 35549910

Group type: EXPERIMENTAL
Intervention: Surgery for displaced wrist fractures
Number of subjects: 19

Group type: COMPARATOR
Intervention: Cast without surgery for displaced wrist fractures
Number of subjects: 19
Study: 32331084

Group type: EXPERIMENTAL
Intervention: Valbenazine 40mg
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Valbenazine 80mg to 40mg
Number of subjects: 67
Study: 35477498

Group type: EXPERIMENTAL
Intervention: Web-based self-learning program (six modules)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group (no intervention during initial phase)
Number of subjects: 0
Study: 34048358

Group type: EXPERIMENTAL
Intervention: Guided Relaxation-Based Virtual Reality (VR-GR)
Number of subjects: 51
Study: 34848351

Group type: EXPERIMENTAL
Intervention: Intrauterine administration of activated peripheral blood mononuclear cells (PBMC) at a dose of 1.106 cells on day 2 (D2) after stimulation with phytohemagglutinin (PHA) and human chorionic gonadotropin (hCG) for 48 hours.
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group received sperm-washing medium.
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: PBMC at D2 after hCG activation.
Number of subjects: 213
Study: 32606319

Group type: EXPERIMENTAL
Intervention: Standardized genetic marker system using 14 novel STR loci identified from 64 samples.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Genetic diversity analysis in Chengdu Zoo population (n=25)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Genetic diversity analysis in Pingwu wild population (n=8)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Individual identification method using seven markers.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Paternity tests conducted on seven offspring with known mothers.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Genotyping database established for captive and wild populations.
Number of subjects: 64
Study: 36436281

Group type: EXPERIMENTAL
Intervention: AGS-v PLUS
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: AGS-v PLUS/ISA-51
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: AGS-v PLUS/Alhydrogel
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 34407805

Group type: EXPERIMENTAL
Intervention: Male involvement in family planning (FP) education
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Women's education on FP
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study: 32087143

Group type: EXPERIMENTAL
Intervention: 0.18 mg fluocinolone acetonide insert
Number of subjects: 129

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 129
Study: 34010631

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus aspirin
Number of subjects: 6564

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 6564
Study: 32187170

Group type: EXPERIMENTAL
Intervention: Urethral CT-positive/GC-negative test visits with extragenital testing
Number of subjects: 139718

Group type: EXPERIMENTAL
Intervention: Overall positivity for GC
Number of subjects: 139718

Group type: EXPERIMENTAL
Intervention: Overall positivity for CT
Number of subjects: 139718

Group type: EXPERIMENTAL
Intervention: Urethral positivity for GC
Number of subjects: 139718

Group type: EXPERIMENTAL
Intervention: Urethral positivity for CT
Number of subjects: 139718

Group type: EXPERIMENTAL
Intervention: Rectal positivity for GC
Number of subjects: 139718

Group type: EXPERIMENTAL
Intervention: Rectal positivity for CT
Number of subjects: 139718

Group type: EXPERIMENTAL
Intervention: Pharyngeal positivity for GC
Number of subjects: 139718

Group type: EXPERIMENTAL
Intervention: Pharyngeal positivity for CT
Number of subjects: 139718
Study: 34924394

Group type: EXPERIMENTAL
Intervention: Skin care plus makeup therapy (n = 18)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Skin care (control group, n = 16)
Number of subjects: 34
Study: 34124246

Group type: EXPERIMENTAL
Intervention: TheraBand
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: theratube
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 30
Study: 36379267

Group type: EXPERIMENTAL
Intervention: Working hours > 28 hours
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Irregular working times
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: No/little freedom in performance tasks
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Requiring physical strength
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: High physical workload
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: No/little freedom in performing tasks
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Working conditions not in accordance with guidelines
Number of subjects: 383
Study: 33944923

Group type: EXPERIMENTAL
Intervention: Financial incentives for statin therapy adherence
Number of subjects: 636

Group type: COMPARATOR
Intervention: Nonimprovement group
Number of subjects: 636
Study: 33290171

Group type: EXPERIMENTAL
Intervention: Bimodality surgical-based settings (tonsillectomy + neck dissection + radiotherapy)
Number of subjects: 4720

Group type: EXPERIMENTAL
Intervention: Surgical-based treatments
Number of subjects: 4720

Group type: EXPERIMENTAL
Intervention: Surgically treated group (HPV-negative patients)
Number of subjects: 4720

Group type: COMPARATOR
Intervention: HPV-positive patients
Number of subjects: 4720
Study: 34784557

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative hypotension
Number of subjects: 0
Study: 35024638

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral and mindfulness-based stress reduction (COBMINDEX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 0
Study: 36236451

Group type: EXPERIMENTAL
Intervention: Super Kids Adventure (SUKIA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nintendo Switch (NINS)
Number of subjects: 24
Study: 34628275

Group type: EXPERIMENTAL
Intervention: Interpersonal negative mood induction
Number of subjects: 86

Group type: COMPARATOR
Intervention: General negative mood induction
Number of subjects: 86

Group type: COMPARATOR
Intervention: Interpersonal neutral mood induction
Number of subjects: 86
Study: 33124792

Group type: EXPERIMENTAL
Intervention: Element-based functional training (EBFT)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Task-specific-based functional training (TSBFT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 47
Study: 33397438

Group type: EXPERIMENTAL
Intervention: Adjusted multi-biomarker disease activity (MBDA) score
Number of subjects: 953

Group type: COMPARATOR
Intervention: Conventional risk factors (seropositivity, DAS28-CRP, CRP, SJC, CDAI)
Number of subjects: 953
Study: 33328259

Group type: EXPERIMENTAL
Intervention: Kinesio taping with tension (KTT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Kinesio taping without tension (KTNT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (attended a class on KOA)
Number of subjects: 45
Study: 35143676

Group type: EXPERIMENTAL
Intervention: Access to electricity
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Poverty status
Number of subjects: 122

Group type: COMPARATOR
Intervention: Objective sleep measures for mothers
Number of subjects: 122

Group type: COMPARATOR
Intervention: Objective sleep measures for children
Number of subjects: 122
Study: 33951213

Group type: EXPERIMENTAL
Intervention: MiSight® 1 day contact lens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated progressing myopes (control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Emmetropes (virtual cohorts)
Number of subjects: 0
Study: 34051728

Group type: EXPERIMENTAL
Intervention: Performance-based financing scheme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non-incentivized antenatal care)
Number of subjects: 0
Study: 32449296

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) of the primary sensory cortex
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Oral capsaicin
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intra-pharyngeal electrical stimulation (IPES)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 36
Study: 36079769

Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 1064

Group type: COMPARATOR
Intervention: NutrInform
Number of subjects: 1064
Study: 34270731

Group type: EXPERIMENTAL
Intervention: Gabapentinoids
Number of subjects: 203

Group type: COMPARATOR
Intervention: Opioids (use of >40 morphine milligram equivalent before implantation)
Number of subjects: 203
Study: 32552383

Group type: EXPERIMENTAL
Intervention: Freezing of gait (FoG)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Fear of falling (FoF) and anxiety
Number of subjects: 153
Study: 35381867

Group type: EXPERIMENTAL
Intervention: Diuretics (DT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Volume Expansion (VE)
Number of subjects: 60
Study: 34715530

Group type: EXPERIMENTAL
Intervention: SENSE program (parent education and age‐appropriate, positive sensory interventions for parents to conduct with their infants every day of hospitalization)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 70
Study: 32674237

Group type: EXPERIMENTAL
Intervention: 50 g of red furu
Number of subjects: 23

Group type: COMPARATOR
Intervention: 50 g of tofu
Number of subjects: 23
Study: 35129441

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation at 6,000 IU/day (D6 group)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation at 200,000 IU/month (D200 group)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Comparison between D6 group and D200 group
Number of subjects: 262
Study: 34732513

Group type: EXPERIMENTAL
Intervention: Participatory learning and action (PLA) groups scaled up by government frontline workers in Jharkhand, eastern India.
Number of subjects: 51949

Group type: COMPARATOR
Intervention: Delayed intervention start (control group).
Number of subjects: 51949

Group type: EXPERIMENTAL
Intervention: Participatory women's groups scaled up by the Indian public health system.
Number of subjects: 51949
Study: 34477899

Group type: EXPERIMENTAL
Intervention: Enhanced Consultation (EC)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard Consultation (SC)
Number of subjects: 64
Study: 34187384

Group type: EXPERIMENTAL
Intervention: Therapeutic pain neuroscience education (TPNE; n = 25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT; n = 25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Multimodal (MM; n = 25)
Number of subjects: 75
Study: 35697087

Group type: EXPERIMENTAL
Intervention: Music intervention (listening to music at bedtime for 4 weeks)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 112
Study: 33544990

Group type: EXPERIMENTAL
Intervention: O-R toothbrush (Oral-B iO)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Sonic brush (Philips Sonicare DiamondClean)
Number of subjects: 110
Study: 32557298

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34877731

Group type: EXPERIMENTAL
Intervention: ≥2 iMAP symptoms associated with 'mild-moderate' non-IgE-mediated CMA
Number of subjects: 1303

Group type: EXPERIMENTAL
Intervention: ≥2 iMAP symptoms associated with 'severe' non-IgE-mediated CMA
Number of subjects: 1303

Group type: COMPARATOR
Intervention: ≥2 mild-moderate symptoms
Number of subjects: 1303

Group type: COMPARATOR
Intervention: ≥2 severe symptoms
Number of subjects: 1303

Group type: COMPARATOR
Intervention: Mean monthly reporting of ≥2 mild-moderate symptoms
Number of subjects: 1303

Group type: COMPARATOR
Intervention: Mean monthly reporting of ≥2 severe symptoms
Number of subjects: 1303
Study: 33962809

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) injection
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Piezocision
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (contralateral sides)
Number of subjects: 24
Study: 32640027

Group type: EXPERIMENTAL
Intervention: Cerebrolysin plus donepezil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Donepezil alone
Number of subjects: 0
Study: 33837400

Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 153
Study: 32252684

Group type: EXPERIMENTAL
Intervention: Capecitabine plus Bevacizumab (Cap+Bev)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Everolimus plus Exemestane (Eve+Exe)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Arm A (Cap+Bev first-line, Eve+Exe second-line)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Arm B (Eve+Exe first-line, Cap+Bev second-line)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Quality of Life (QoL)
Number of subjects: 77
Study: 35666507

Group type: EXPERIMENTAL
Intervention: Novel online group-coaching program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Better Together Physician Coaching
Number of subjects: 0
Study: 34388396

Group type: EXPERIMENTAL
Intervention: Teclistamab (subcutaneous at 1500 μg/kg once per week after step-up doses of 60 μg/kg and 300 μg/kg)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Teclistamab (subcutaneous at 1500 μg/kg once per week)
Number of subjects: 157
Study: 32463701

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 27
Study: 35781772

Group type: EXPERIMENTAL
Intervention: Bicarbonate-rich mineral water
Number of subjects: 51

Group type: COMPARATOR
Intervention: Plain water
Number of subjects: 51
Study: 34755760

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (50 mg/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no early fibrinogen replacement)
Number of subjects: 32
Study: 33332582

Group type: EXPERIMENTAL
Intervention: 6-week guided self-help mindfulness-based intervention (MBI)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Routine treatment (wait-list control)
Number of subjects: 144
Study: 32972265

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 33858504

Group type: EXPERIMENTAL
Intervention: SVF
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 32032256

Group type: EXPERIMENTAL
Intervention: MNV3 lesions distribution
Number of subjects: 78
Study: 35681088

Group type: EXPERIMENTAL
Intervention: Endogenous IGF-1 levels
Number of subjects: 49
Study: 33373969

Group type: EXPERIMENTAL
Intervention: Doramectin 200 μg/kg live weight (LW)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline solution 1 mL/50 kg LW (Control)
Number of subjects: 20
Study: 32653895

Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) 50 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 33715537

Group type: EXPERIMENTAL
Intervention: Automated Messaging (AM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 50
Study: 33319651

Group type: EXPERIMENTAL
Intervention: Progesterone treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34637336

Group type: EXPERIMENTAL
Intervention: Nivolumab plus low-dose ipilimumab
Number of subjects: 45
Study: 34172591

Group type: EXPERIMENTAL
Intervention: THINK (n = 46)
Number of subjects: 76

Group type: COMPARATOR
Intervention: CON (n = 30)
Number of subjects: 76
Study: 33535224

Group type: EXPERIMENTAL
Intervention: Early insulin treatment in VLBW infants
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard care in VLBW infants
Number of subjects: 105

Group type: COMPARATOR
Intervention: Term AGA infants
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Total group of children
Number of subjects: 105
Study: 36062524

Group type: EXPERIMENTAL
Intervention: Immediate postpartum contraceptive implants (IPI)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Non-IPI (alternative method or no contraception)
Number of subjects: 194
Study: 32970162

Group type: EXPERIMENTAL
Intervention: Cystus® tea mouthwash solution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sage tea mouthwash solution
Number of subjects: 60
Study: 32634551

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) 24 weeks, 3 days per week, moderate intensity
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 157
Study: 35457579

Group type: EXPERIMENTAL
Intervention: Yogurt group (YGT-G) consuming a yogurt drink (9.3 g protein, 39 g CHO, 192 kcal) after IWT
Number of subjects: 103

Group type: COMPARATOR
Intervention: Carbohydrate group (CHO-G) consuming jelly (45 g CHO, 180 kcal) after IWT
Number of subjects: 103
Study: 32421603

Group type: EXPERIMENTAL
Intervention: Intensive Short-Term Dynamic Psychotherapy (ISTDP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Community Mental Health Teams (CMHT)
Number of subjects: 60
Study: 35775194

Group type: EXPERIMENTAL
Intervention: MPS1 Inhibitor (BAY 1217389) in combination with Paclitaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 32476258

Group type: EXPERIMENTAL
Intervention: COVID-19 treatment modalities in SOT patients
Number of subjects: 10
Study: 35742385

Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking + Smoking-Related Illness (EFT + SRI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Episodic Recent Thinking (ERT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Episodic Recent Thinking + Smoking-Related Illness (ERT + SRI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EFT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SRI
Number of subjects: 0
Study: 32970811

Group type: EXPERIMENTAL
Intervention: Audit and feedback intervention group
Number of subjects: 1856

Group type: COMPARATOR
Intervention: Control group (participation in a national registry)
Number of subjects: 1856
Study: 32943290

Group type: EXPERIMENTAL
Intervention: In-person contact before SAH
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: In-person contact during SAH
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: In-person contact by SAH week 6
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Alcohol consumption and in-person contacts
Number of subjects: 50